Abnormal Uterine Bleeding (AUB) is common

Under-reported, under-treated and normalized

AUB in our communities

Women with AUB have poor health related quality of life, below the 25th percentile of that of the general population³.

The price she pays: Direct costs of AUB – $1 billion

The price we all pay: Indirect costs of AUB – $12 billion

AUB around the world

In an international online survey study of 6,179 women aged 18–55

How many women in your community are quietly dealing with the burden of AUB?

• 36% had either been diagnosed with heavy menstrual bleeding (HMB) or thought their menstruation was heavier than average, a common symptom of AUB
• 41% of these women believed there were no treatment options available for them
• Menstrual flow outside of normal volume, duration, regularity, or frequency is considered abnormal uterine bleeding (AUB)
• One-third of outpatient visits to the gynecologist are for AUB1
• AUB accounts for more than 70% of all gynecologic consults in the perimenopausal and post-menopausal years

We are The Uterine Health Company

Minerva Surgical provides device-enabled solutions for AUB that are uterus-sparing, minimally invasive, safe and effective.

In 2020, Minerva Surgical acquired three additional devices for the treatment of AUB, creating a complete, best-in-class intrauterine care kit.

We’re here to help optimize the delivery of care to those suffering from AUB by offering on-demand support to assist your team.

For support contact us at: meetminerva@minervasurgical.com

• Transitioning treatments to the office setting
• In-office hysteroscopy supplies checklist
• In-office polypectomy supplies checklist
• In-office endometrial ablation supplies checklist
• Pain management & anesthesia guidelines brochure*
• Reimbursement information
• VAC presentation support
• Patient outreach programs